Global Hemostasis Testing Thromboelastography: Old Technology, New Applications

Clinics in Laboratory Medicine

Volumn 29, Issue 2, 2009, Pages 391-407

  Chen, Alice ^a   Teruya, Jun ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Central laboratory; Hemostasis; Review; Thromboelastography; Whole blood assay

Indexed keywords

BLOOD CLOTTING FACTOR 12; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

BLEEDING; BLOOD CLOTTING FACTOR 13 DEFICIENCY; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; DIAGNOSTIC VALUE; DISSEMINATED INTRAVASCULAR CLOTTING; DYSFIBRINOGENEMIA; GLANZMANN DISEASE; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; HYPOFIBRINOGENEMIA; PARTIAL THROMBOPLASTIN TIME; POLYCYTHEMIA; PRIORITY JOURNAL; PROTHROMBIN TIME; RELIABILITY; REVIEW; THROMBOELASTOGRAPHY; VON WILLEBRAND DISEASE;

ANIMALS; BLOOD COAGULATION DISORDERS; FACTOR XII; HUMANS; MONITORING, PHYSIOLOGIC; PLATELET AGGREGATION INHIBITORS; POLYCYTHEMIA; THROMBELASTOGRAPHY;

EID: 68249146371     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2009.04.003     Document Type: Review

References (44)

1. Hartert H. Blutgerninnungstudien mit der thromboelastographic, einen neven untersuchingsver fahren. Klin Wochenschr 16 (1948) 257-260 [German]
2. Howland W.S., Castro E.B., Fortner J.B., et al. Hypercoagulability-thromboelastographic monitoring during extensive hepatic surgery. Arch Surg 108 (1974) 605-608
3. Kang Y.C., Martin D.J., Marquez J., et al. Intraoperative changes in blood coagulation and thromboelastographic monitoring in liver transplantation. Anesth Analg 64 (1985) 888-896
4. Spiess B.D., Tuman K.J., McCarthy R.J., et al. Thromboelastography as an indicator of postcardiopuomonary bypass coagulopathies. J Clin Monit 3 1 (1987) 25-30
5. Mallett S.V., and Cox D.J. Thromboelastography. Br J Anaesth 69 (1992) 307-313
6. Tuman K.J., McCarthy R.J., Djuric M., et al. Evaluation of coagulation during cardiopuomonary bypass with a heparinase-modified thromboelastographic assay. J Cardiothorac Vasc Anesth 8 (1994) 144-149
7. Luddington R.J. Thromboeastography/thromboelastometry. Clin Lab Haematol 27 (2005) 81-90
8. Jackson G.N.B., Ashpole K.J., and Yentis S.M. The TEG vs the ROTEM thromboelastography/thromboelastometry systems. Anaesthesia 64 (2009) 212-215
9. Depotis G.J., Joist J.H., and Goodnough L.T. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 43 9 (1997) 1684-1696
10. Shore-Lesserson L., Manspeizer H.E., DePerio M., et al. Thromboelastography-guided transfusion algorithm reduces transfusion in complex cardiac surgery. Anesth Analg 88 2 (1999) 312-319
11. Frumento R.J., Hirsh A.L., Parides M.K., et al. Difference in arterial and venous thromboelastography paramteters: potential roles of shear stress and oxygen content. J Cardiothorac Vasc Anesth 16 5 (2002) 551-554
12. Dirkmann D., Hanke A.A., Gorlinger K., et al. Perioperative use of modified thromboelastography in factor XI deficiency: a helpful method to assess drug effects. Acta Anaesthesiol Scand 51 (2007) 640-643
13. Welsby I.J., Jiao K., Orgel T.L., et al. The kaolin-activated thromboelastograph predicts bleeding after cardiac surgery. J Cardiothorac Vasc Anesth 20 4 (2006) 531-535
14. Thalheimer U., Triantos C.K., Samonakis D.N., et al. A comparison of kaolin-activated versus nonkaolin-activated thromboelastography in native and citrated blood. Blood Coagul Fibrinolysis 19 6 (2008) 495-501
15. Johansson P.I., Bochsen L., Andersen S., et al. Investigation of the effect of kaolin and tissue factor-activated citrated whole blood, on clot-forming variables, as evaluated by thromboelastography. Transfusion 48 (2008) 2377-2383
16. Kettner S.C., Pollack A., Zimpfer M., et al. Heparinase-modified thromboelastography in term and preterm neonates. Anesth Analg 98 (2004) 1650-1652
17. Edwards R.M., Naik-Mathuria B., Gay N., et al. Parameters of thromboelastography in the normal newborns. Am J Clin Pathol 130 (2008) 99-102
18. Miller B.E., Bailey J.M., Mancuso T.J., et al. Functional maturity of the coagulation system in children: an evaluation using thromboelastography. Anesth Analg 84 4 (1997) 745-748
19. Grant H.W., and Hadley G.P. Prediction of neonatal sepsis by thromboelastography. Pediatr Surg Int 12 (1997) 289-292
20. Zavadil D.P., Stammers A.H., Willett L.D., et al. Hematological abnormalities in neonatal patients treated with extracorporeal membrane oxygenation (ECMO). J Extra Corpor Technol 30 2 (1998) 83-90
21. Ikemori R., Gruhl M., Shrivastava S., et al. Solubility of fibrin clots in monochloroacetic acid. A reflection of serum pepsinogen levels. Am J Clin Pathol 63 1 (1975) 49-56
22. Miller J. Hemostasis and thrombosis. In: McPherson R.A., and Pincus M.R. (Eds). Henry's clinical diagnosis and management by laboratory methods. 21st edition (2007), Saunders Elsevier, Philadelphia 742
23. Nielse V.G., Gurley Jr. W.Q., and Burch T.M. The impact of factor XIII on coagulation kinetics and clot strength determined by thromboelastography. Anesth Analg 99 (2004) 120-123
24. Lovejoy A.E., Reynolds T.C., Visich J.E., et al. Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency. Blood 108 (2006) 57-62
25. Macieira S., Rivard G.E., Champagne J., et al. Glanzmann thrombasthenia in an Oldenbourg filly. Vet Clin Pathol 36 2 (2007) 204-208
26. Male C., Koren D., Eichelberger B., et al. Monitoring survival and function of transfused platelets in Glanzmann thrombasthenia by flow cytometry and thrombelastography. Vox Sang 91 (2006) 174-177
27. Lak M., Scharling B., Blemings A., et al. Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram. Haemophilia 14 (2008) 103-110
28. McDonagh J. Dysfibrinogenemia and other disorders of fibrinogen structure of function. In: Colman R.W., Hirsh J., Marder V.J., et al. (Eds). hemostasis and thrombosis-basic principles and clinical practice. 4th edition (2001), Lippincott Williams & Wilkins, Philadelphia 855
29. Cunningham M.T., Brandt J.T., Laposata M., et al. Laboratory diagnosis of dysfibrinogenemia. Arch Pathol Lab Med 126 4 (2002) 499-505
30. Roberts H.R., and Escobar M.A. Disorders of fibrinogen. In: Kitchens C.S., Alving B.M., and Kessler C.M. (Eds). Consultative hemostasis and thrombosis. 2nd edition (2007), Saunders/Elsevier 64-65
31. Forman W.B., Ratnoff O.D., and Boyer M.H. An inheritied qualitative abnormality in plasma fibrinogen: fibrinogen Cleveland. J Lab Clin Med 72 (1968) 455-472
32. McCrath D.J., Cerboni E., Frumento, et al. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 100 6 (2005) 1576-1583
33. Hvitfeldt Poulsen L., Christiansen K., Sorensen B., et al. Whole blood thromboelastographic coagulation profiles using minimal tissue factor activation can display hypercoagulation in thrombosis-prone patients. Scand J Clin Lab Invest 66 4 (2006) 329-336
34. LaBelle C., and Kitchens C.S. Disseminated intravascular coagulation. In: Kitchens C.S., Alving B.M., and Kessler C.M. (Eds). Consultative hemostasis and thrombosis. 2nd edition (2007), Saunders/Elsevier, Philadelphia 183-196
35. Toh C.H., and Hoots W.K. The scoring system of the Scientific and Standardization Committee on disseminated intravascular coagulation of the international society on thrombosis and haemostasis: a 5-year overview. J Thromb Haemost 5 (2007) 604-606
36. Nichols W.L., Nultin M.B., James A.H., et al. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) expert panel report (USA). Haemophilia 14 (2008) 171-232
37. Kawaguchi C., Takahashi Y., Hanesaka Y., et al. The in vitro analysis of the coagulation mechanism of activated factor VII using thromboelastogram. Thromb Haemost 88 (2002) 768-772
38. Hendriks H.G., Meijer K., de Wolf J.T., et al. Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation. Blood Coagul Fibrinolysis 13 (2002) 309-313
39. Shibata J., Hasegawa J., Siemens H.J., et al. Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis. Blood 101 11 (2003) 4416-4422
40. Swallow R.A., Agarwala R.A., Dawkins K.D., et al. Thromboelastography: potential bedside tool to assess the effects of antiplatelet therapy?. Platelets 17 6 (2006) 385-392
41. Agarwal S., Coakely M., Reddy K., et al. Quantifying the effect of antiplatelet therapy. Anesthesiology 105 4 (2006) 676-683
42. Martini W.Z., Cortez D.S., Dubick M.A., et al. Thromboelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotteing abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. J Trauma 65 3 (2008) 535-543
43. Chitlur M., Warrier I., Rajpurkar M., et al. Thromboelastography in children with coagulation factor deficiencies. Br J Haematol 142 (2008) 250-256
44. Ghosh K., Shetty S., and Kulkarni B. Correlation of thromboelastographic patterns with clinical presentation and rationale for use of antifibrinolytics in severe haemophilia patients. Haemophilia 13 6 (2007) 734-739